Invention Grant
- Patent Title: Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
-
Application No.: US16014133Application Date: 2018-06-21
-
Publication No.: US11299536B2Publication Date: 2022-04-12
- Inventor: Matthew J. Frigault , Yangbing Zhao , John Scholler , Carl H. June
- Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
- Applicant Address: US PA Philadelphia
- Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
- Current Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
- Current Assignee Address: US PA Philadelphia
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Kathryn Doyle
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C12N5/0783 ; C07K16/30 ; C12N15/86 ; C07K14/725 ; C07K14/705

Abstract:
The present invention provides compositions and methods for generating a genetically modified T cells comprising a chimeric antigen receptor (CAR) having an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain, wherein the T cell exhibits prolonged exponential expansion in culture that is ligand independent and independent of the addition of exogenous cytokines or feeder cells.
Public/Granted literature
Information query